Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-41.06	1.86	3.15
Graham Fair Price	29.21	25219.88	19519.26
PEG	-47.18	0.07	0.14
Price/Book	-1.96	0.39	0.39
Price/Cash Flow	-29.24	6.38	9.02
Prices/Earnings	-40.08	4.66	7.77
Price/Sales	-5.31	1.06	1.12
Price/FCF	-29.24	6.38	9.02
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.01	0.36	0.36
Operating Margin	6.20	0.16	0.15
ROA	61.10	< 0.005	< 0.005
ROE	0.01	0.02	63.62
ROIC	0.04	0.05	23.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.46	92.53
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.11	0.11	1.45
EPS QOQ	0.58	0.65	13.44
FCF QOQ	0.36	0.40	10.79
Revenue QOQ	-0.01	0.05	287.10
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.05	38.57	-18.02
Days Sales Outstanding (DSO)	26.68	27.60	3.44
Inventory Turnover	1.91	2.33	21.98
Debt/Capitalization	0.05	0.05	-4.19
Quick Ratio	2.67	1.78	-33.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	36513.32	36882.31	1.01
Cash	18995.35	12434.36	-34.54
Capex	-592.82	-498.81	15.86
Free Cash Flow	1598.82	2237.51	39.95
Revenue	12889.64	13480.67	4.59
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.27	2.25	-31.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.61	-2.25	-40.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating